Skip to content

Company information lookup

PATRYS LIMITED (PAB)

Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PAB 0.023 0% 0.023 0.024 0.024 0.024 0.023 862,544

PATRYS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PAB
Securities
Official Listing Date 13 July, 2007
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.patrys.com
Registered Office Address Suite 614, Level 6 Equitable House, 343 Little Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (03) 9670 3273
Head Office Fax (03) 9670 3247
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr John Read (Non Exec. Chairman)
Dr Marie Roskrow (Managing Director, CEO)
Ms Suzy Jones (Non Exec. Director)
Mr Michael Stork (Non Exec. Director)
Mr Roger McPherson (CFO)
Company Secretary Mr Roger McPherson
Principal Activities Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

PATRYS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
29/08/2014 asterix Preliminary Final Report - 30 June 2014 14 PDF
25/08/2014 asterix Patrys - Details of PAT-SM6 & Carfilzomib Clinical Trial 2 PDF
18/08/2014 asterix Patrys to Present at German Hematology Congress 2 PDF
24/07/2014 asterix Patrys Reports Progress on Preclinical Programmes 2 PDF
21/07/2014 asterix Appendix 4C - Quarterly Cash Flow - June 2014 5 PDF
18/06/2014 asterix Patrys Granted Third US Patent for PAT-SM6 2 PDF
04/06/2014   Patrys' CEO Presents at Asia Biotech Invest 2014 19 PDF
28/05/2014 asterix Positive Response for PAT-SM6 in Combination Therapy 2 PDF
20/05/2014   Appendix 3B 12 PDF
11/04/2014 asterix Appendix 4C - Quarterly Cash Flow - March 2014 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
01 Sep 2014 0.023 -4.17% 0.024 0.023 862,544
29 Aug 2014 0.024 0% 0.024 0.024 565,500
28 Aug 2014 0.024 0% 0.024 0.023 740,000
27 Aug 2014 0.024 4.35% 0.024 0.023 419,500
26 Aug 2014 0.023 0% 0.023 0.022 2,016,667

* Volume of shares shown represents only those shares traded on ASX.

PATRYS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PAB. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PAB

Warrants & Structured Products

No warrants & Structured Products are available over the security PAB

ASX CFDs

No Contracts For Differences are available over the security PAB